Subtype
Brain Neoplasm
CI-CAN-00002030Explore in graph →
Non-malignant512 active trials34 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002030Explore in graph →
Clinical trials
2,118 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00994071 | A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors | completed | Phase 1 | 9 | National Cancer Institute (NCI)NIH | 1 | Dec 9, 2019 | clinicaltrials |
| NCT01251913 | A Pilot Study of Inpatient Hospice With Procurement of Brain Tumor Tissue on Expiration for Research Purposes | terminated | — | 7 | National Cancer Institute (NCI)NIH | 1 | Dec 3, 2019 |
| clinicaltrials |
| NCT01540513 | PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404 | completed | N/A | 12 | University of Wisconsin, MadisonOTHER | 1 | Dec 2, 2019 | clinicaltrials |
| NCT04051047 | Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma | withdrawn | Early Phase 1 | 0 | University of Michigan Rogel Cancer CenterOTHER | 1 | Nov 27, 2019 | clinicaltrials |
| NCT04178057 | Phase I Clinical Study of GB222 to Evaluate the Safety, Tolerability and PK Profiles. | unknown | Phase 1 | 24 | Genor Biopharma Co., Ltd.INDUSTRY | 1 | Nov 27, 2019 | clinicaltrials |
| NCT04180501 | SRS Sequential Sindilimab in Brain Metastasis of NSLSC | unknown | Phase 2 | 25 | Xiaorong DongOTHER | 1 | Nov 27, 2019 | clinicaltrials |
| NCT04178330 | Tomotherapy as Primary Radiotherapy for Multipule Brain Metastases | completed | N/A | 82 | Chinese Academy of Medical SciencesOTHER | 1 | Nov 26, 2019 | clinicaltrials |
| NCT00775320 | Assessment of Suspected Intracranial Malignancy Using 3'-Deoxy-3'18 F-flourothymidine PET | terminated | — | 13 | University of OklahomaOTHER | 1 | Nov 25, 2019 | clinicaltrials |
| NCT02357498 | Transsphenoidal Extent of Resection Study(TRANSSPHER) | completed | N/A | 260 | St. Joseph's Hospital and Medical Center, PhoenixOTHER | 1 | Nov 25, 2019 | clinicaltrials |
| NCT02727686 | Post-Operative Water Load Following Transsphenoidal Pituitary Surgery | completed | N/A | 30 | St. Joseph's Hospital and Medical Center, PhoenixOTHER | 1 | Nov 25, 2019 | clinicaltrials |
| NCT01392209 | Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma | completed | Phase 1 | 15 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 22, 2019 | clinicaltrials |
| NCT02692898 | Biomarker Analysis of Central Nervous System Tumors | terminated | — | 12 | National Cancer Institute (NCI)NIH | 1 | Nov 19, 2019 | clinicaltrials |
| NCT01516905 | PET/CT Imaging of Malignant Brain Tumors With 124I-NM404 | completed | — | 19 | University of Wisconsin, MadisonOTHER | 1 | Nov 15, 2019 | clinicaltrials |
| NCT01654497 | Dexanabinol in Patients With Brain Cancer | completed | Phase 1 | 26 | Santosh Kesari, M.D., Ph.D.OTHER | 1 | Nov 14, 2019 | clinicaltrials |
| NCT01272622 | Prospective Study of Children and Adolescents With Craniopharyngioma | completed | N/A | 120 | Klinikum Oldenburg gGmbHOTHER | 1 | Nov 6, 2019 | clinicaltrials |
| NCT02775136 | An Evaluation of a Non-invasive Brain Monitor | unknown | N/A | 160 | HeadSense MedicalINDUSTRY | 1 | Oct 30, 2019 | clinicaltrials |
| NCT00049127 | Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor | completed | Phase 1 / Phase 2 | 64 | Alliance for Clinical Trials in OncologyOTHER | 1 | Oct 21, 2019 | clinicaltrials |
| NCT01202539 | Real-time Assessment of Frameless Intrafraction Motion | withdrawn | — | 0 | Oregon Health and Science UniversityOTHER | 1 | Oct 3, 2019 | clinicaltrials |
| NCT01806675 | 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy | completed | Phase 1 / Phase 2 | 25 | Sanjiv Sam GambhirOTHER | 1 | Oct 3, 2019 | clinicaltrials |
| NCT04113278 | Role of Fibirnogen Like Protein 2 as Aprognostic Factor in High Grade Glioma | unknown | — | 1 | sohaila EssamOTHER | 0 | Oct 2, 2019 | clinicaltrials |
| NCT02537106 | A Comparison of the Effect of 1.5 Versus 3% NaCl on Brain Relaxation and Microcirculation | completed | N/A | 100 | University Hospital Hradec KraloveOTHER | 1 | Oct 1, 2019 | clinicaltrials |
| NCT03577600 | Compassionate Treatment in Children With Brain Tumors With the Cytotron® | withdrawn | N/A | 0 | Hospital Infantil de Mexico Federico GomezOTHER | 1 | Sep 24, 2019 | clinicaltrials |
| NCT04065204 | Metabolomic Analysis of Body Fluid of Medulloblastoma in Children | unknown | — | 100 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Sep 23, 2019 | clinicaltrials |
| NCT00977795 | A Study of the Specificity and Sensitivity of 5-ALA Fluorescence in Malignant Brain Tumors | withdrawn | Phase 1 / Phase 2 | 0 | Endeavor HealthOTHER | 0 | Sep 10, 2019 | clinicaltrials |
| NCT02689336 | Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors | withdrawn | Phase 2 | 0 | Washington University School of MedicineOTHER | 0 | Sep 9, 2019 | clinicaltrials |
| NCT03721055 | Fluoroglutamine PET/CT in Imaging Patients With Malignant Tumor | unknown | N/A | 60 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Sep 6, 2019 | clinicaltrials |
| NCT01182350 | Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG) | terminated | Phase 2 | 53 | Karen D. Wright MDOTHER | 1 | Sep 4, 2019 | clinicaltrials |
| NCT01065805 | A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma | terminated | Phase 1 / Phase 2 | 94 | AHS Cancer Control AlbertaOTHER | 1 | Aug 22, 2019 | clinicaltrials |
| NCT02045368 | Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R | completed | Phase 1 | 92 | IGF Oncology, LLCINDUSTRY | 1 | Aug 22, 2019 | clinicaltrials |
| NCT01454596 | CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII | completed | Phase 1 / Phase 2 | 18 | National Cancer Institute (NCI)NIH | 1 | Aug 21, 2019 | clinicaltrials |
| NCT01014767 | Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors | terminated | Phase 3 | 27 | Tufts Medical CenterOTHER | 4 | Aug 20, 2019 | clinicaltrials |
| NCT01966809 | Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas | terminated | Phase 2 | 1 | Harry T Whelan, MDOTHER | 1 | Aug 20, 2019 | clinicaltrials |
| NCT03632317 | A Study of Panobinostat in Combination With Everolimus for Children and Young Adults With Gliomas | withdrawn | Phase 2 | 0 | University of Michigan Rogel Cancer CenterOTHER | 1 | Aug 19, 2019 | clinicaltrials |
| NCT04058704 | A Study to Determine the Efficiency For Brain Metastasis NSCLC Patients Treated With Icotinib Alone or Combined With Radiation Therapy(SMART) | unknown | Phase 3 | 296 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Aug 15, 2019 | clinicaltrials |
| NCT01514201 | Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas | completed | Phase 1 / Phase 2 | 66 | National Cancer Institute (NCI)NIH | 1 | Aug 13, 2019 | clinicaltrials |
| NCT00027846 | Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma | completed | Phase 2 | 378 | Children's Oncology GroupNETWORK | 6 | Aug 7, 2019 | clinicaltrials |
| NCT00238264 | Radiation Therapy in Treating Young Patients With Gliomas | completed | Phase 2 | 92 | Children's Oncology GroupNETWORK | 6 | Aug 7, 2019 | clinicaltrials |
| NCT03997136 | Prognostic Impact of Surgical Resection Extent for Supratentorial High Grade Gliomas. | unknown | — | 28 | Assiut UniversityOTHER | 0 | Aug 7, 2019 | clinicaltrials |
| NCT02629549 | Intraoperative Imaging of Pituitary Adenomas by OTL | terminated | Phase 1 | 33 | University of PennsylvaniaOTHER | 1 | Aug 6, 2019 | clinicaltrials |
| NCT03409549 | Multi-parametric MRI/Fluorine-18 Fluciclovine PET-CT in Glioblastoma | unknown | — | 12 | The Leeds Teaching Hospitals NHS TrustOTHER | 1 | Aug 6, 2019 | clinicaltrials |
| NCT01212237 | Dose Response of Functionally Critical Brain Regions for Brain Radiotherapy | withdrawn | — | 0 | Weill Medical College of Cornell UniversityOTHER | 1 | Jul 29, 2019 | clinicaltrials |
| NCT02409121 | A Novel Health Information Technology System (BMT Roadmap) for Pediatric BMT Patients and Caregivers | completed | N/A | 59 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jul 29, 2019 | clinicaltrials |
| NCT02031237 | MRI Study of Changes in Blood-Brain/Tumor-Barrier Permeability in Patients With Brain Metastases During and After Radiotherapy | completed | — | 52 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jul 26, 2019 | clinicaltrials |
| NCT00423735 | Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma | completed | Phase 2 | 64 | National Cancer Institute (NCI)NIH | 3 | Jul 24, 2019 | clinicaltrials |
| NCT00884741 | Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma | completed | Phase 3 | 637 | National Cancer Institute (NCI)NIH | 3 | Jul 24, 2019 | clinicaltrials |
| NCT03778541 | HFSRT With Concurrent TMZ for Large BMs | unknown | Phase 3 | 224 | Chinese Academy of Medical SciencesOTHER | 1 | Jul 23, 2019 | clinicaltrials |
| NCT02393131 | Neurocognitive Outcome of Conformal WBRT w/wo Hippocampal Avoidance for Brain Metastases | unknown | N/A | 70 | National Taiwan University HospitalOTHER | 1 | Jul 19, 2019 | clinicaltrials |
| NCT02530749 | Frailty as a Predictor of Neurosurgical Outcomes in Brain Tumor Patients | completed | — | 265 | University of Colorado, DenverOTHER | 1 | Jul 11, 2019 | clinicaltrials |
| NCT02603692 | Health Related Quality of Life in Pediatric Central Nervous System (CNS) Tumors: A Feasibility Study Utilizing PROMIS(PROMIS-QOL) | completed | — | 20 | Children's Hospital Medical Center, CincinnatiOTHER | 1 | Jul 11, 2019 | clinicaltrials |
| NCT03392545 | Combination of Immunization and Radiotherapy for Malignant Gliomas (InSituVac1)(InSituVac1) | unknown | Phase 1 | 30 | Beijing Tiantan HospitalOTHER | 1 | Jul 11, 2019 | clinicaltrials |
Data updated 24 days agoSource updated Dec 9, 2019source: clinicaltrials